Skip to main content

Search

Show all results for

Home

Person

Natacha Anne-Sophie Bordry

This person is no longer with EPFL

About
Privacy
Disclaimer

Copyright © 2026 EPFL, all rights reserved

Graph Chatbot

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related publications (5)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

Melody Swartz, Davide Demurtas, Lambert Charles François Potin, Patricia Corthésy Henrioud, Léa Maillat, Romain Hamelin, Natacha Anne-Sophie Bordry, Maria Anna Sofia Broggi, Alexandre Harari

Liquid biopsies allow monitoring of cancer progression and detection of relapse, but reliable biomarkers in melanoma are lacking. Because secreted factors preferentially drain to lymphatic vessels before dilution in the blood, we hypothesized that lymph sh ...

ROCKEFELLER UNIV PRESS2019

Lymphatic vessel density is associated with CD8(+) T cell infiltration and immunosuppressive factors in human melanoma

Melody Swartz, Olivier Michielin, Natacha Anne-Sophie Bordry, Manuel Andreas Fankhauser, Esther Danenberg, Maria Anna Sofia Broggi, Timothy Murray

Increased density of tumor-associated lymphatic vessels correlates with poor patient survival in melanoma and other cancers, yet lymphatic drainage is essential for initiating an immune response. Here we asked whether and how lymphatic vessel density (LVD) ...

TAYLOR & FRANCIS INC2018

T cell–induced CSF1 promotes melanoma resistance to PD1 blockade

Sina Nassiri, Krisztian Homicsko, Natacha Anne-Sophie Bordry, Michele De Palma, Laure Tillé, Esther Danenberg, Christophe Martignier, George Coukos

Colony-stimulating factor 1 (CSF1) is a key regulator of monocyte/macrophage differentiation that sustains the protumorigenic functions of tumor-associated macrophages (TAMs). We show that CSF1 is expressed in human melanoma, and patients with metastatic m ...

2018